GfK – Factors Supporting a Sustainable European Biosimilar Medicines Market

9 September 2014

Report

A study about the future sustainability of the biosimilar medicines […]

KPMG Report: Advice on the implementation of EU-Directive 2011/62/EU

22 February 2013

Report

According to the European Commission (hereinafter ‘EC’) of the European […]

EGA Q&A on the Revised EMA Bioequivalence Requirement

22 June 2010

Report

Generic Medicines: Essential Contributor to the Long-Term Health of Society

21 March 2010

Report

Patent-Related Barriers to Market Entry for Generic Medicines in the European Union

30 June 2009

Report

How to Increase Patient Access to Generic Medicines

30 June 2009

Report